Whan In Pharm Co.,Ltd. (KRX:016580)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,320
+20 (0.18%)
Dec 30, 2025, 3:30 PM KST
-4.71%
Market Cap172.82B
Revenue (ttm)256.32B
Net Income (ttm)15.17B
Shares Out15.27M
EPS (ttm)978.53
PE Ratio11.57
Forward PE12.26
Dividend300.00 (2.65%)
Ex-Dividend DateDec 29, 2025
Volume22,281
Average Volume24,910
Open11,480
Previous Close11,300
Day's Range11,210 - 11,480
52-Week Range10,050 - 13,210
Beta0.22
RSI39.41
Earnings DateFeb 13, 2026

About Whan In Pharm

Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceutical products in South Korea. The company offers products such as gastrointestinal, respiratory, cardiovascular, antidiabetic, antibiotic, antifungal, antihistamine, antiviral, antirheumatic, muscle relaxant, nonsteroidal anti-inflammatory, smoking cessation, erectile dysfunction, prostate disease, urinary disorder, osteoporosis, antiseizure, antidepressant, antipsychotic, central nervous system stimulant, anti-dementia, nootropic, alcohol use disorder, anti-Parkinson, multivitamin... [Read more]

Sector Healthcare
Founded 1978
Employees 601
Stock Exchange Korea Stock Exchange
Ticker Symbol 016580
Full Company Profile

Financial Performance

In 2024, Whan In Pharm's revenue was 259.60 billion, an increase of 12.68% compared to the previous year's 230.39 billion. Earnings were 23.38 billion, a decrease of -21.47%.

Financial Statements

News

There is no news available yet.